Hiroomi Tada

2022

In 2022, Hiroomi Tada earned a total compensation of $1.3M as Chief Medical Officer at Tyra Biosciences, a 50% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$215,600
Option Awards$563,937
Salary$486,250
Other$950
Total$1,266,737

Tada received $563.9K in option awards, accounting for 45% of the total pay in 2022.

Tada also received $215.6K in non-equity incentive plan, $486.3K in salary and $950 in other compensation.

Rankings

In 2022, Hiroomi Tada's compensation ranked 2,570th out of 5,707 executives tracked by ExecPay. In other words, Tada earned more than 55.0% of executives.

ClassificationRankingPercentile
All
2,570
out of 5,707
55th
Division
Manufacturing
1,421
out of 3,105
54th
Major group
Chemicals And Allied Products
644
out of 1,406
54th
Industry group
Drugs
598
out of 1,307
54th
Industry
Pharmaceutical Preparations
428
out of 953
55th
Source: SEC filing on April 18, 2024.

Tada's colleagues

We found three more compensation records of executives who worked with Hiroomi Tada at Tyra Biosciences in 2022.

2022

Ali Fawaz

Tyra Biosciences

General Counsel

2022

Daniel Bensen

Tyra Biosciences

Chief Operating Officer

2022

Todd Harris

Tyra Biosciences

Chief Executive Officer

News

You may also like